Macolax (13.125 gm+350.7 mg+178.5 mg+46.6 mg)/25 ml (Oral Solution)
100 ml bottle: ৳ 160.00
Medicine Details
Category | Details |
---|---|
Generic | Polyethylene glycol 3350 electrolytes |
Company | Opsonin pharma ltd |
Indications
- Effective relief from constipation
- Treatment of chronic constipation
- Resolving fecal impaction
Composition
- Polyethylene Glycol 3350
- Sodium Chloride
- Sodium Bicarbonate
- Potassium Chloride
Mode of Action
- Exerts osmotic action in the gut
- Increases stool volume
- Triggers colon motility
- Facilitates defecation
- Exchanges electrolytes across intestinal barrier
- Unabsorbed from the gastrointestinal tract
Dosage & Administration
- 1 sachet daily for constipation
- 8 sachets daily for fecal impaction
- No dosage change for renal insufficiency
- Dissolve sachet in water
- Store solution refrigerated
- Oral solution dosage and administration
Interaction
- Possibility of transiently reduced absorption of other medicinal products
- Reports of decreased efficacy with some concomitantly administered medicinal products
Contraindications
- Intestinal perforation or obstruction
- Ileus
- Severe inflammatory conditions of the intestinal tract
- Toxic megacolon
- Hypersensitivity to the active substances
Side Effects
- Allergic reactions
- Electrolyte disturbances
- Abdominal pain
- Diarrhea
- Headache
- Peripheral edema
Pregnancy & Lactation
- No anticipated effects during pregnancy
- Can be used during pregnancy
- No anticipated effects on the breastfed newborn/infant
- Can be used during breastfeeding
Precautions & Warnings
- Dosage precautions for impaired cardiovascular function
- Symptoms indicating shifts of fluid/electrolytes
- Prolonged use may lead to dependence
Overdose Effects
- Severe pain or distention treatment
- Correction of electrolyte disturbances for extensive fluid loss
Therapeutic Class
- Osmotic purgatives
Storage Conditions
- Store below 30°C
- Protect from light
- Do not refrigerate
Related Brands
- Movilax (13.125 gm+350.7 mg+178.5 mg+46.6 mg)/sachet (Oral Powder) - incepta-pharmaceuticals-ltd
- Movilax (13.125 gm+350.7 mg+178.5 mg+46.6 mg)/25 ml (Oral Solution) - incepta-pharmaceuticals-ltd
- GOL (13.125 gm+350.7 mg+178.5 mg+46.6 mg)/25 ml (Oral Solution) - square-pharmaceuticals-plc
- Movifast (13.125 gm+350.7 mg+178.5 mg+46.6 mg)/sachet (Oral Powder) - ziska-pharmaceuticals-ltd
- Laxogol (13.125 gm+350.7 mg+178.5 mg+46.6 mg)/25 ml (Oral Solution) - acme-laboratories-ltd